Conversely, many of the upregulated hub genes, such as MAOB (Figure 9A) (HR = 0.66, p = 0.00026), SLC6A3 (Figure 9B) (HR = 0.56, p = 0.000042), DHX58 (Figure 9E) (HR = 0.72, p = 0.0033), TRDN (Figure 9G) (HR = 0.69, p = 0.0083), CYP2E1 (Figure 9H) (HR = 0.76, p = 0.026), and IFIT3 (Figure 9K)) (HR = 0.75, p = 0.02), were correlated with improved overall breast cancer patient survival. The gene discussed is IFIT3; the disease is breast cancer.